Continuous bioprocessing refers to the use of continuous manufacturing technologies for biopharmaceutical drug production as opposed to batch manufacturing which has traditionally been used. In continuous bioprocessing, bioreactors operate in a steady state where cells are maintained in an active growing environment and product is continually being harvested rather than operated in batches. Some key benefits of continuous bioprocessing include increased productivity, reduced manufacturing costs, improved process consistency and product quality.

Advantages of Continuous Bioprocessing over Batch Processing

There are several advantages that continuous bioprocessing offers over traditional batch manufacturing methods:

Improved Productivity: Continuous processes allow for uninterrupted production since multiple cycles can be run simultaneously. This improves overall equipment and facility utilization leading to a higher number of product units being produced in a given timeframe.

Lower Cost of Goods: The higher productivity of continuous processes directly translates to lower costs of goods sold on a per unit basis. Additionally, continuous processes require smaller facility footprints and reduced overheads since multiple production cycles can operate simultaneously.

Consistency and Quality: Continuous biomanufacturing ensures a steadier biological environment with consistent culture and operating conditions. This tightly controlled environment promotes consistent product quality and attributes from one batch to the next giving more reproducible results.

Flexibility: Continuous processes are highly flexible and scalable. Production capacity can easily be adjusted up or down by increasing or decreasing the number of simultaneous production cycles operating. This gives better capacity utilization and demand matching.

Continuous Bioprocessing  - https://www.coherentmi.com/blog/continuous-bioprocessing-is-revolutionizing-the-biopharmaceutical-industry-128